SecBot SecBot
SECBOTREPLAY Home › Report › ALNY

ALNY · CWI stake 10.4%

ALNYLAM PHARMACEUTICALS, INC. · SC 13G/A filed Nov 13, 2026 at 13:51 ET

At the news

NEUTRALIMPACT 2/10

SC 13G/A filed Nov 13, 2026 at 13:51 ET

Capital World Investors filed an amended Schedule 13G disclosing a 10.4% passive stake in Alnylam Pharmaceuticals as of September 30, 2026, up from a prior filing. This is a routine update for a large passive holder and does not signal any change in investment intent or control.

  • Capital World Investors reported beneficial ownership of 13,934,539 shares of Alnylam common stock, representing 10.4% of shares outstanding as of September 30, 2026.
  • The filing is an amendment to Schedule 13G, certifying passive investment intent under Rule 13d-1(b).
  • The stake increased from the prior filing (May 2026), which disclosed a lower percentage but no exact prior figure is stated in this document.
  • The filing was made on November 13, 2026, with a signature date of November 11, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access